General MedicationsORALGeneric
POTASSIUM AMINOSALICYLATE
POTASSIUM AMINOSALICYLATE
Standard Dose
100%
Max Dose
Refer to approved labeling
Primary Use
Marketing status: Discontinued
Summary
Approval overview POTASSIUM AMINOSALICYLATE is listed in Drugs@FDA under application 080098 (ANDA).
Marketing status: Discontinued Active ingredient POTASSIUM AMINOSALICYLATE Form and strength POWDER;ORAL - 100% Sponsor HEXCEL Submission history Latest submission status date: 1971-04-14 00:00:00.
Structured Monograph
Clinical summary
Approval overview POTASSIUM AMINOSALICYLATE is listed in Drugs@FDA under application 080098 (ANDA). Marketing status: Discontinued Active ingredient POTASSIUM AMINOSALICYLATE Form and strength POWDER;ORAL - 100% Sponsor HEXCEL Submission history Latest submission status date: 1971-04-14 00:00:00. Submission type: ORIG.
Monitoring
- • Marketing status: Discontinued
Interaction Notes
- No interaction notes stored yet.